Separation method

US11667671B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11667671-B2
Application numberUS-202016911511-A
CountryUS
Kind codeB2
Filing dateJun 25, 2020
Priority dateMay 11, 2016
Publication dateJun 6, 2023
Grant dateJun 6, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method of isolating an immunoglobulin, comprising the steps of:a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml;b) contacting a liquid sample comprising an immunoglobulin with the separation matrix;c) washing the separation matrix with a washing liquid;d) eluting the immunoglobulin from the separation matrix with an elution liquid; ande) cleaning the separation matrix with a cleaning liquid comprising at least 0.5 M NaOH.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of isolating an immunoglobulin, comprising the steps of: a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein said porous support comprises cross-linked polymer particles having a pore size corresponding to an inverse gel filtration chromatography Kd value of 0.69-0.85 for dextran of Mw 110 kDa; b) contacting a liquid sample comprising an immunoglobulin with said separation matrix; c) washing said separation matrix with a washing liquid; d) eluting the immunoglobulin from the separation matrix with an elution liquid; and e) cleaning the separation matrix with a cleaning liquid comprising more than 2M NaOH, wherein in step e) the contact time between the separation matrix and the cleaning liquid is 3 minutes or less. 2. The method of claim 1 , wherein said separation matrix has a maximum pressure of at least 0.58 MPa when packed at 300+/−10 mm bed height in a chromatography column having a diameter of 35 mm. 3. The method of claim 1 , wherein said immunoglobulin comprises an Fc fusion protein. 4. The method of claim 1 , wherein said immunoglobulin has a hydrodynamic radius of at least 6.0 nm. 5. The method of claim 1 , wherein said immunoglobulin comprises a bispecific, trispecific or polyspecific antibody. 6. The method of claim 5 , wherein said method separates half antibodies or homodimeric antibodies from said bispecific, trispecific or polyspecific antibody. 7. The method of claim 1 , wherein said immunoglobulin comprises a conjugated antibody. 8. The method of claim 1 , wherein said immunoglobulin comprises an antibody fragment. 9. The method of claim 1 , wherein the separation matrix is a Protein A chromatography column. 10. The method of claim 1 , wherein steps b)-e) are repeated at least 10 times. 11. The method of claim 1 , wherein in step b) the pH is 6-8. 12. The method of claim 1 , wherein in step b) the residence time of said liquid sample on said separation matrix is 2-20 min. 13. The method of claim 1 , which is performed in a continuous or semicontinuous multicolumn chromatography process. 14. The method of claim 1 , which is performed in a periodic countercurrent chromatography (PCC) process. 15. The method of claim 1 , wherein the separation matrix is an antibody affinity chromatography cross-linked agarose matrix having alkaline-stabilized protein A-derived ligands.

Assignees

Inventors

Classifications

  • Affinity chromatography or related techniques based upon selective absorption processes · CPC title

  • C07K16/00Primary

    Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title

  • using two or more columns · CPC title

  • Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation · CPC title

  • based on polymers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11667671B2 cover?
The invention relates to a method of isolating an immunoglobulin, comprising the steps of:a) providing a separation matrix comprising at least 15 mg/ml multimers of immunoglobulin-binding alkali-stabilized Protein A domains covalently coupled to a porous support, wherein the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 microme…
Who is the assignee on this patent?
Cytiva Bioprocess R & D Ab
What technology area does this patent fall under?
Primary CPC classification C07K16/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).